GL1X · GenesisL1 explorer

Research workbench

NMR2 Structure of KRAS G12V (GMPPNP bound) in complex with 5-(1H-indol-2-l)piperazin-2-one

Analyse NMR2 Structure of KRAS G12V (GMPPNP bound) in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
8PI0
Type
protein
Length
168 residues
Chains
1
Method
solution nmr
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
NOT
Source
Homo sapiens
Molecule
V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, isoform CRA_b
UniProt
A0A024RAV5
Ligands
YVW
Pockets
5 · best druggability 0.78

Structure

solution nmr · resolution NOT · 1 distinct chain · 37% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, isoform CRA_bprotein16837% helix, 23% strandA0A024RAV5

Ligands and binding sites

  • YVW · (5~{S})-5-(1~{H}-indol-2-yl)piperazin-2-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11030.780.9735empty
21370.660.8828YVW
31110.610.8632empty
4500.330.7812empty
5530.330.7816empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.